CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia.
Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
B-ALL 患者中循环 Trm 样细胞亚群升高,该亚群高表达细胞增殖和耗竭相关基因。这些 T 细胞向 Teff 或 Tex 的双向发育潜能分别与良好或不良预后密切相关。总之,我们的研究提供了对白血病相关 T 细胞改变的独特见解,也为 B-ALL 患者展示了潜在的免疫治疗方向和预后评估模型。
白血病相关 T 细胞的特征和组成与患者的治疗反应和预后密切相关。尽管 B 细胞急性淋巴细胞白血病(B-ALL)患者已从免疫治疗方法中获益,例如CAR-T 细胞疗法,但其中部分患者仍预后不良,尤其是成年患者。因此,迫切需要深入理解 T 细胞亚型之间的发育关系及其与 B-ALL 患者预后的关联。
我们分析了三名B-ALL患者的外周血T细胞单细胞RNA测序数据,并以11名健康个体的数据作为对照。总共客观分析了来自B-ALL患者和健康成年人的16,143个和53,701个T细胞,详细划分出13个不同的T细胞集群。以集群特异性基因作为标记基因,对每个T细胞亚型进行注释。
无偏分析使得发现循环CD103+ T细胞(CD3+CD103+MKI67+),也称为组织驻留记忆样T(Trm样)细胞,在B-ALL患者中升高,其表达高水平的细胞增殖和耗竭相关基因。此外,细胞命运轨迹分析显示,这些Trm样细胞与耗竭T(Tex)细胞和效应T(Teff)细胞共享T细胞受体(TCR)克隆型,被认为会转变为Teff细胞;然而,在白血病环境中主要转化为Tex细胞。更重要的是,Trm样细胞向Teff细胞和Tex细胞的转化可能分别导致B-ALL患者有利或不良的预后。
We analyzed the peripheral blood T cell single-cell RNA sequencing data of three B-ALL patients, using data from 11 healthy individuals as controls. In total, 16,143 and 53,701 T cells from B-ALL patients and healthy adults, respectively, were objectively analyzed for detailed delineation of 13 distinct T cell clusters. Cluster-specific genes were used as marker genes to annotate each T cell subtype.
Unbiased analysis enabled the discovery of circulating CD103+ T cell (CD3+CD103+MKI67+), also defined as tissue-resident memory-like T (Trm-like) cell, populations were elevated in B-ALL patients, which expressed high level of cell proliferation and exhaustion related genes. In addition, cell fate trajectory analysis showed these Trm-like cells, which shared T-cell receptor (TCR) clonotypes with exhausted T (Tex) cells and effector T (Teff) cells, were supposed to transition into Teff cells; however, mainly transformed into Tex cells in leukemia environment. More importantly, Trm-like cells transformation into Teff cells and Tex cells potentially led to favorable or poor prognosis for B-ALL patients, respectively.
In sum, a circulating Trm-like cell subset with high level expression of cell proliferation and exhaustion related genes was elevated in B-ALL patients. The bidirectional developmental potential of these T cells into Teff or Tex is closely associated with favorable or poor prognosis, respectively. Together, our study provided a unique insight of alteration of leukemia related T cells, also showed a potential immunotherapy direction and prognosis assessment model for B-ALL patients.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。